Introduction to Genetics: Women’s Imaging & Breast Care Centers
35 minute clinical education webinar with 10 min live QA. Covering the basics of integrating genetic testing in high risk breast cancer screening for imaging center staff, supervisors, nurse navigators, patient and breast navigators and mammo technologists. Hosted by a Certified Genetic Counselor.
- Discuss how genetic testing improves patient care and care management access for those at increased risk for breast cancer
- Review the basics of breast cancer genetics and hereditary cancer inheritance patterns
- Discuss ways to efficiently identify patients at increased risk for breast cancer and how to order testing
- Understand how genetic testing can enhance and compliment image based risk assessments
- Review patient case studies and prepare to address common patient questions including cost and coverage
Breast Cancer Detected by Mammography is Too Late – Know More Sooner
“One of the biggest drawbacks for the imaging center is time – we work on a very tight schedule, with maybe 15-20 min slots for patients. Integrating hereditary cancer screening is absolutely doable in that amount of time. Start small in the beginning and you will soon show your worth by identifying all these people that are at high risk for cancer with no idea they carry a genetic mutation they pass down through their family.”
Genetic testing is the only tool to identify women who have increased cancer risk beyond family history
“Identifying patients at increased risk of developing breast and other cancers due to a family history of breast and other cancers or a known hereditary cancer syndrome can have dramatic effects on early detection and cancer outcomes. For this reason, cancer risk assessment and genetic counseling has become the standard of care for patients with a personal and/or family history of breast cancer.”
It matters to patients
BRCA1 Mutation Carrier, Breast Cancer Survivor
High-quality, personalized breast care doesn't have to be complicated
Elevate Your Practice with EmpowerTM
- Empower screens for genes associated with increased risk for common hereditary cancers. Our Empower multi-cancer panels include commonly screened-for genes associated with 12+ types of cancer.
- Empower helps families understand their risk of developing cancer and informs both screening and treatment options.
Natera is a proud partner of PenRad Technologies and Volpara Health. Together, these mammography reporting systems are used with >50% of women who attend breast screenings each year in the United States. Click below to learn how to add a genetics module to your existing workflow.
Integrated workflows to simplify breast cancer risk assessment for every patient
Natera provides clinician resources like paper and digital screening tools, including Natera’s Education Virtual Assistant to collect a complete personal and family history intake.
Connect your patients with board-certified genetic counselors to help them understand what to expect during genetic testing or to review results.
Empower results offer a single look at genetic findings, Tyrer-Cuzick score, and mammogram results, for a complete view of breast cancer risk.
Do you want to identify more women at risk for hereditary cancer?
We can help you get started
1Houssami N, Hunter K. The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening. NPJ Breast Cancer. 2017 Apr 13;3:12. doi: 10.1038/s41523-017-0014-x. PMID: 28649652; PMCID: PMC5460204.
2Irvin VL, Zhang Z, Simon MS, et al. Comparison of Mortality Among Participants of Women’s Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers. JAMA Netw Open. 2020;3(6):e207227. doi:10.1001/jamanetworkopen.2020.7227
3Loving et al. A Breast Radiology Department-operated, Proactive Same-day Program Identifies Pathogenic Breast Cancer Mutations in Unaffected Women. Academic Radiology. https://doi.org/10.1016/j.acra.2020.12.005